Lipella Pharmaceuticals LIPO
LIPO
$0.00 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lipella Pharmaceuticals Inc. (LIPO) Income from Continuing Operations (2022 - 2025)

Updated

Lipella Pharmaceuticals' Income from Continuing Operations was -$1.25 million in Q3 2025, compared with -$1.44 million a year earlier.

Analysis

Lipella Pharmaceuticals Inc. (LIPO) Income from Continuing Operations (2022 - 2025) Analysis & Trends

On a trailing twelve-month basis, Lipella Pharmaceuticals' Income from Continuing Operations was -$5.33 million through Sep 30, 2025; for FY2024, it was -$5.02 million.

  • In earlier years, Income from Continuing Operations was -$4.62 million in FY2023, -$2.6 million in FY2022 and -$1.87 million in FY2021.
  • The Q3 2025 figure marks the highest quarterly Income from Continuing Operations since Q2 2024.
  • Per Business Quant data, LIPO's Income from Continuing Operations in the three quarters before Q3 2025 was -$1.33 million (Q2 2025), -$1.31 million (Q1 2025) and -$1.44 million (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.25 Mn
Jun 30, 2025 -1.33 Mn
Mar 31, 2025 -1.31 Mn
Dec 31, 2024 -1.44 Mn
Sep 30, 2024 -1.44 Mn
Jun 30, 2024 -938,146.00
Mar 31, 2024 -1.19 Mn
Dec 31, 2023 -688,884.00
Sep 30, 2023 -1.32 Mn
Jun 30, 2023 -1.54 Mn
Mar 31, 2023 -1.07 Mn
Dec 31, 2022 -363,925.00
Sep 30, 2022 -713,794.00
Jun 30, 2022 -782,024.00
Mar 31, 2022 -737,950.00
API Access

Lipella Pharmaceuticals Inc. Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=LIPO&period=max&api_key=YOUR_API_KEY